trending Market Intelligence /marketintelligence/en/news-insights/trending/X_Mht6iLYn8-lGsGw1WxwQ2 content esgSubNav
In This List

Aratana Therapeutics starts common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Aratana Therapeutics starts common stock offering

Aratana Therapeutics Inc. started an underwritten public offering for $35 million of its common stock.

The company also plans to grant the underwriters an option to buy up to an additional $5.3 million of its common stock.

Barclays and Credit Suisse are acting as joint book-running managers for the offering.